Mark Kessel's Net Worth
-$79.9 Thousand
Who is Mark Kessel?
Mark Kessel does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DYNAVAX TECHNOLOGIES CORP, ORGANOVO HOLDINGS, INC., OXIGENE INC, ANTIGENICS INC /DE/, and Alexza Pharmaceuticals Inc..
SEC CIK
Mark Kessel's CIK is 0001222013
Past Insider Trading and Trends
2005 was Mark Kessel's most active year for acquiring shares with 5 total transactions. Mark Kessel's most active month to acquire stocks was the month of December. 2004 saw Mark Kessel paying a total of $191,748.00 for 22,800 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $10.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -66.43% | -6.00M |
$4.73 | -$28,356,000.00 | 3.03M |
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +8.28% | 690.63K |
—
|
—
| 9.03M |
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ORGANOVO HOLDINGS, INC. (ONVO) Snapshot price: $0.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OXIGENE INC (OTLC) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +27.78% | 25K |
$0.23 | $5,750.00 | 115K |
Jan 2
| |||
Form 4
| +0.09% | 25K |
$0.38 | $9,502.50 | 27.3M |
Jul 1
| |||
Form 4
| +116.67% | 35K |
$1.14 | $39,900.00 | 65K |
Jan 2
| |||
Form 4
|
∞
| 30K |
$1.14 | $34,200.00 | 30K |
Dec 8
| |||
Form 4
| +58.42% | 10M |
$1.25 | $12,480,000.00 | 27.12M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANTIGENICS INC /DE/ (AGEN) Snapshot price: $4.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8 - Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
| No matching records found | |||||||||
Alexza Pharmaceuticals Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||